Advanced Search

    column
    Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma
    LIN Ning-jing, ZHU Jun
    2020, 20(2): 65-71. DOI: 10.12019/j.issn.1671-5144.2020.02.001
    Abstract FullText HTML PDF
    The Efficacy of Polatuzumab Vedotin with Bendamustine and Rituximab （pola-BR） versus Bendamustine and Rituximab （BR） in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    YING Zhi-tao, HUANG Ling
    2020, 20(2): 72-75. DOI: 10.12019/j.issn.1671-5144.2020.02.002
    Abstract FullText HTML PDF
    PET-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of HD16 Trial
    BAO Hui-zheng, WEI Xiao-juan
    2020, 20(2): 76-79. DOI: 10.12019/j.issn.1671-5144.2020.02.003
    Abstract FullText HTML PDF
    Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
    Reviewers: LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo
    2020, 20(2): 80-82. DOI: 10.12019/j.issn.1671-5144.2020.02.004
    Abstract FullText HTML PDF
    Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance
    Reviewer: LI Wen-yu, CHEN Fei-li
    2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
    Abstract FullText HTML PDF
    ECHELON-2 Study: Curative Effect Analysis of Brentuximab Vedotin with CHP Chemotherapy for CD30-Positive Peripheral T-Cell Lymphoma
    Reviewers: YANG Chun-li, ZOU Li-qun
    2020, 20(2): 85-88. DOI: 10.12019/j.issn.1671-5144.2020.02.006
    Abstract FullText HTML PDF
    The Relationship of 14-3-3ζ Protein Expression and Gastric Cancer: A Meta-Analysis
    ZHANG Ya-ting, LI Pei, HE Yi-di, LI Yi-tong, LI Yu-min
    2020, 20(2): 89-95. DOI: 10.12019/j.issn.1671-5144.2020.02.007
    Abstract FullText HTML PDF
    Effect of CKAP2 on Human Retinal Vascular Endothelial Cells Cultured in High Glucose and Its Mechanism
    CHEN Xiang-ting, XIE Jie, MENG Qian-li
    2020, 20(2): 96-102. DOI: 10.12019/j.issn.1671-5144.2020.02.008
    Abstract FullText HTML PDF
    Evaluation of the Effect of Low Abdominal Aorta Balloon Occlusion on Reducing Blood Loss during Giant Sacral Tumor Resection
    CHEN Si-nan, OU Yun-sheng, LI Kai, JIANG Dian-ming
    2020, 20(2): 103-107. DOI: 10.12019/j.issn.1671-5144.2020.02.009
    Abstract FullText HTML PDF
    Differentiation of Human Embryonic Stem Cells into Pulmonary Artery Smooth Muscle-Like Cells in Vitro
    HUANG Zi-rui, LI Xiao-hong, CHEN Jing, QIU Min, HE Biao-chuan, OU Yan-qiu, ZHOU Cheng-bin, ZHUANG Jian, CHEN Ji-mei
    2020, 20(2): 108-114. DOI: 10.12019/j.issn.1671-5144.2020.02.010
    Abstract FullText HTML PDF
    The Role of Study Nurses in the Whole-Process Management of Clinical Trials
    GAN Bin, YANG Yan, LUO Su-fen, ZHENG Xiao-ying, CHEN Xiao-ling, ZENG Shuai, CHEN Xiu-mei, ZHOU Qing, WU Yi-long
    2020, 20(2): 115-120. DOI: 10.12019/j.issn.1671-5144.2020.02.011
    Abstract FullText HTML PDF
    The Prognosis of Mutation Subtypes of KRAS Gene and Their Relation with the Expression Level of PD-L1 in Advanced Lung Adenocarcinoma
    FENG Hui-bo, XIE Zhi, ZHONG Yu-min, JIANG Jie, CHEN Yu, GUO Wei-bang, LV Zhi-yi, YAN Wen-qing, SU Jian, ZHANG Shui-lian, ZHANG Xu-chao
    2020, 20(2): 121-124. DOI: 10.12019/j.issn.1671-5144.2020.02.012
    Abstract FullText HTML PDF
    Assessment of the Effect on Prevention of Venous Thromboembolism （VTE） in Wards of Elderly Patients by Two-Way Communication Management of Both Patients and Medical Professionals
    WANG Xiao-xia, XU Zhi-hong, WANG Fei-fei, DENG Si-si, CHEN Qiu-ju
    2020, 20(2): 125-128. DOI: 10.12019/j.issn.1671-5144.2020.02.013
    Abstract FullText HTML PDF